Drug Target Review

APRIL 19, 2024

Sibylla’s scientific founders come from very different scientific fields that do not usually speak to each other, such as theoretical physics, molecular biology and pharmaceutical chemistry. And so, I have been the managerial co-founder and CEO of Sibylla since 2017. Identifying new drugs is an extremely complex project.

Molecular Biology 111

Molecular Biology Research Pharmaceuticals Small Molecule 111

Elrig

APRIL 29, 2024

With a background in Bioinformatics and Computational Biology, she has a keen interest in using technology to solve problems in healthcare and medicine. Having a combination of computational skills & scientific knowledge such as molecular biology, genomics is also important. big pharma or startups/spin off?

Bioinformatics 59

Bioinformatics Drugs Molecular Biology Cell Based Assays 59

Vial

MARCH 1, 2024

Introduction Contract research organizations (CROs) are essential in pharmaceutical research and development (R&D). A 2022 survey by McKinsey found that emerging biotech companies are less satisfied with their CROs than large pharma companies and reported the feeling of being underserved.

Clinical Trials 52

Clinical Trials Clinical Research Trials Laboratories 52

Codon

FEBRUARY 13, 2024

3 Another considerable obstacle to pharmaceutical companies’ interest (and investment) is the fact that for a product to be patentable — and therefore profitable — it has to be considered new and inventive. Because frankly, do you know of anything else that can work against multiple drug-resistant bacteria?

Therapies 128

Therapies Virus DNA Clinical Trials 128